Scholars@Duke

The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.

Publication ,  Journal Article
D'Alessio, DA; Kahn, SE
Published in: Diabetes Care
January 1, 2025
Published version (DOI) Link to item

Duke Scholars

David A D'Alessio
Author David A D'Alessio Medicine, Endocrinology, Metabolism, and Nutrition

Published In

Diabetes Care

DOI

10.2337/dci24-0092

EISSN

1935-5548

Publication Date

January 1, 2025

Volume

48

Issue

1

Start / End Page

3 / 5

Location

United States

Related Subject Headings

  • Endocrinology & Metabolism
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
D’Alessio, D. A., & Kahn, S. E. (2025). The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research. Diabetes Care, 48(1), 3–5. https://doi.org/10.2337/dci24-0092
D’Alessio, David A., and Steven E. Kahn. “The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.” Diabetes Care 48, no. 1 (January 1, 2025): 3–5. https://doi.org/10.2337/dci24-0092.
D’Alessio, David A., and Steven E. Kahn. “The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.” Diabetes Care, vol. 48, no. 1, Jan. 2025, pp. 3–5. Pubmed, doi:10.2337/dci24-0092.

Published In

Diabetes Care

DOI

10.2337/dci24-0092

EISSN

1935-5548

Publication Date

January 1, 2025

Volume

48

Issue

1

Start / End Page

3 / 5

Location

United States

Related Subject Headings

  • Endocrinology & Metabolism
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences